[go: up one dir, main page]

MXPA05006296A - Uso de tiazolobenzoheterociclos para el tratamiento de la esclerosis multiple. - Google Patents

Uso de tiazolobenzoheterociclos para el tratamiento de la esclerosis multiple.

Info

Publication number
MXPA05006296A
MXPA05006296A MXPA05006296A MXPA05006296A MXPA05006296A MX PA05006296 A MXPA05006296 A MX PA05006296A MX PA05006296 A MXPA05006296 A MX PA05006296A MX PA05006296 A MXPA05006296 A MX PA05006296A MX PA05006296 A MXPA05006296 A MX PA05006296A
Authority
MX
Mexico
Prior art keywords
thiazolobenzoheterocycles
multiple sclerosis
treating multiple
inflammatory
compound
Prior art date
Application number
MXPA05006296A
Other languages
English (en)
Inventor
Petty Margaret
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of MXPA05006296A publication Critical patent/MXPA05006296A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invencion se refiere al uso de un compuesto de Formula I en el tratamiento de pacientes con dolor inflamatorio o neuropatico, asi como en diversos sintomas de la esclerosis multiple. (ver Formula (I)).
MXPA05006296A 2002-12-17 2003-12-16 Uso de tiazolobenzoheterociclos para el tratamiento de la esclerosis multiple. MXPA05006296A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43400302P 2002-12-17 2002-12-17
PCT/US2003/040078 WO2004058271A1 (en) 2002-12-17 2003-12-16 Use of thiazolobenzoheterocycles for treating multiple sclerosis

Publications (1)

Publication Number Publication Date
MXPA05006296A true MXPA05006296A (es) 2005-08-29

Family

ID=23722415

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05006296A MXPA05006296A (es) 2002-12-17 2003-12-16 Uso de tiazolobenzoheterociclos para el tratamiento de la esclerosis multiple.

Country Status (10)

Country Link
US (1) US7041661B2 (es)
EP (1) EP1585525B1 (es)
AT (1) ATE488238T1 (es)
AU (1) AU2003300976A1 (es)
BR (1) BR0317413A (es)
CA (1) CA2508222A1 (es)
DE (1) DE60335029D1 (es)
GB (1) GB0307067D0 (es)
MX (1) MXPA05006296A (es)
WO (1) WO2004058271A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110172262A1 (en) 2008-09-15 2011-07-14 Biovista, Inc. Compositions and methods for treating epilepsy
WO2013130422A1 (en) 2012-02-27 2013-09-06 Biovista, Inc. Compositions and methods for treating mitochondrial diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2649701B2 (fr) 1988-12-15 1991-11-22 Rhone Poulenc Sante Derives d'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
FR2766487B1 (fr) * 1997-07-28 1999-08-27 Rhone Poulenc Rorer Sa Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
FR2826004B1 (fr) 2001-06-13 2008-03-28 Aventis Pharma Sa Procede de preparation de derives estrogenes

Also Published As

Publication number Publication date
WO2004058271A1 (en) 2004-07-15
BR0317413A (pt) 2005-11-08
US7041661B2 (en) 2006-05-09
EP1585525B1 (en) 2010-11-17
DE60335029D1 (de) 2010-12-30
CA2508222A1 (en) 2004-07-15
GB0307067D0 (en) 2003-04-30
AU2003300976A1 (en) 2004-07-22
ATE488238T1 (de) 2010-12-15
US20040147504A1 (en) 2004-07-29
EP1585525A1 (en) 2005-10-19

Similar Documents

Publication Publication Date Title
IL175762A0 (en) Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease
MX2010003612A (es) Derivados de oxadiazol.
MX2010003614A (es) Compuestos de diarilo oxadiazol.
EP1673078A4 (en) BENZYL ETHER AND BENZYLAMINO BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE
TW200728305A (en) Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease
UA85559C2 (en) Aminobenzophenone compounds
RS20050810A (en) 5,7-diaminopyrazolo(4,3-d)pyrimidines useful in the treatment of hypertension
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
MXPA05011707A (es) Dihidroquinazolinas sustituidas con propiedades antivirales.
GB0127903D0 (en) Improvements relating to organic compounds
MX2010007026A (es) Derivados de triazoloxadiazoles.
TW200505865A (en) Compounds useful for the treatment of diseases
ECSP024244A (es) Uso de (z)-2-cyano-3-hydroxy-but-2-enoic acid(4´-trifluoromethylphenyl)-amide para el tratamiento de la esclerosis múltiple
TW200630367A (en) Substituted adenines and the uses thereof
UA90698C2 (en) Triazole substituted aminobenzophenone compounds
DE60220385D1 (de) Benzimidazole zur behandlung sexueller fehlfunktionen
DE602004012146D1 (en) Pyrazolopyrimidine
SE0002739D0 (sv) New use
DE602004019500D1 (en) 4-substituirte-5-cyano-1h-pyrimidin-6-(th)iones als als gsk-3-hemmer
MXPA05006296A (es) Uso de tiazolobenzoheterociclos para el tratamiento de la esclerosis multiple.
TW200603801A (en) Novel dialkoxy-imidazopyridines
GB0202645D0 (en) Treatment of chronic neurodegenerative diseases
UA87569C2 (ru) Соединения для лечения расстройств желудочно-кишечной моторики
UA88018C2 (ru) Ингибиторы калиевого канала
TW200613301A (en) Novel amino-halogen-imidazopyridines